严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）黏膜疫苗的递送装置很重要。 - Suppr

The delivery device of SARS-CoV-2 mucosal vaccine matters.

作者信息

Jian Fanchong, Cao Yunlong

机构信息

Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China.

Changping Laboratory, Beijing, China.

出版信息

Nat Immunol. 2024 Oct;25(10):1781-1783. doi: 10.1038/s41590-024-01950-6.

DOI:10.1038/s41590-024-01950-6

PMID:39227515

Abstract

摘要

相似文献

The delivery device of SARS-CoV-2 mucosal vaccine matters.

Nat Immunol. 2024 Oct;25(10):1781-1783. doi: 10.1038/s41590-024-01950-6.

Intranasal COVID-19 vaccines: From bench to bed.

EBioMedicine. 2022 Feb;76:103841. doi: 10.1016/j.ebiom.2022.103841. Epub 2022 Jan 24.

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2.

Hum Vaccin Immunother. 2020 Dec 1;16(12):2921-2931. doi: 10.1080/21645515.2020.1805992. Epub 2020 Sep 15.

An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.

Front Immunol. 2021 Dec 17;12:781280. doi: 10.3389/fimmu.2021.781280. eCollection 2021.

A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates.

J Virol. 2025 Apr 15;99(4):e0199024. doi: 10.1128/jvi.01990-24. Epub 2025 Mar 21.

Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters.

Viruses. 2024 Apr 3;16(4):559. doi: 10.3390/v16040559.

Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals.

mBio. 2025 Jan 8;16(1):e0217024. doi: 10.1128/mbio.02170-24. Epub 2024 Dec 4.

Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters.

Front Immunol. 2024 Aug 30;15:1430928. doi: 10.3389/fimmu.2024.1430928. eCollection 2024.

Intranasal administration of unadjuvanted SARS-CoV-2 spike antigen boosts antigen-specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters.

Eur J Immunol. 2024 Jun;54(6):e2350620. doi: 10.1002/eji.202350620. Epub 2024 Apr 1.

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models.

EBioMedicine. 2022 Jan;75:103762. doi: 10.1016/j.ebiom.2021.103762. Epub 2021 Dec 21.

本文引用的文献

Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates.

Nat Immunol. 2024 Oct;25(10):1913-1927. doi: 10.1038/s41590-024-01951-5. Epub 2024 Sep 3.

Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.

Nature. 2024 Feb;626(7998):385-391. doi: 10.1038/s41586-023-06951-3. Epub 2023 Dec 14.

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial.

Lancet Infect Dis. 2023 Oct;23(10):1143-1152. doi: 10.1016/S1473-3099(23)00350-X. Epub 2023 Jun 20.

Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose.

Lancet Microbe. 2023 Jul;4(7):e488. doi: 10.1016/S2666-5247(23)00102-7. Epub 2023 Apr 20.

Intranasal COVID-19 vaccine fails to induce mucosal immunity.

Nat Med. 2022 Dec;28(12):2439-2440. doi: 10.1038/d41591-022-00106-z.

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses.

Science. 2022 Nov 25;378(6622):eabo2523. doi: 10.1126/science.abo2523.

The T cell immune response against SARS-CoV-2.

Nat Immunol. 2022 Feb;23(2):186-193. doi: 10.1038/s41590-021-01122-w. Epub 2022 Feb 1.

Distribution of Droplets and Immune Responses After Aerosol and Intra-Nasal Delivery of Influenza Virus to the Respiratory Tract of Pigs.

Front Immunol. 2020 Oct 27;11:594470. doi: 10.3389/fimmu.2020.594470. eCollection 2020.

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.

Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The delivery device of SARS-CoV-2 mucosal vaccine matters.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

The delivery device of SARS-CoV-2 mucosal vaccine matters.

作者信息

机构信息

出版信息

相似文献

本文引用的文献